Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 13, 2025

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 243.80	-0.9%	8.3%	CHF 195.4b	CHF 315.38	PE23.4x	E14.5%	4.0%
NOVN Novartis	CHF 86.09	-1.2%	-0.5%	CHF 163.4b	CHF 95.20	PE16.8x	E7.0%	3.6%
LONN Lonza Group	CHF 523.60	8.1%	-1.9%	CHF 37.0b	CHF 656.71	PE58.2x	E21.1%	0.8%
GALD Galderma Group	CHF 76.10	-2.8%	19.5%	CHF 18.1b	CHF 104.88	PE95.9x	E30.4%	n/a
SDZ Sandoz Group	CHF 31.70	0.5%	12.6%	CHF 13.7b	CHF 44.08	PS1.6x	E29.9%	1.7%
SFZN Siegfried Holding	CHF 851.00	4.7%	-4.4%	CHF 3.7b	CHF 1,148.08	PE23.3x	E10.4%	0.4%
BANB Bachem Holding	CHF 46.72	4.7%	-42.6%	CHF 3.5b	CHF 70.71	PE29.1x	E15.8%	1.8%
DESN Dottikon ES Holding	CHF 174.40	2.6%	-25.3%	CHF 2.4b	CHF 350.00	PE31.9x	S16.4%	0%
TECN Tecan Group	CHF 143.90	2.7%	-58.4%	CHF 1.8b	CHF 250.29	PE27.1x	E17.2%	2.1%
SKAN SKAN Group	CHF 61.10	1.5%	-25.3%	CHF 1.4b	CHF 90.67	PE35.4x	E16.3%	0.7%
COPN Cosmo Pharmaceuticals	CHF 46.30	-1.9%	-33.8%	CHF 741.5m	CHF 103.37	PE6x	E26.4%	4.1%
KURN Kuros Biosciences	CHF 17.41	0.3%	122.9%	CHF 660.9m	n/a	PS8.7x	n/a	n/a
PPGN PolyPeptide Group	CHF 14.58	3.1%	-49.9%	CHF 481.1m	CHF 29.85	PS1.5x	E64.4%	0%
BSLN Basilea Pharmaceutica	CHF 39.45	-1.7%	-2.5%	CHF 478.5m	CHF 77.28	PE6.2x	E-10.1%	0%
IDIA Idorsia	CHF 1.03	6.3%	-50.3%	CHF 231.9m	CHF 1.00	PS2.1x	E51.1%	n/a
BIOV BioVersys	CHF 35.00	-0.3%	n/a	CHF 202.1m	CHF 60.00	n/a	n/a	n/a
SANN Santhera Pharmaceuticals Holding	CHF 12.82	-0.3%	38.6%	CHF 161.5m	CHF 25.00	PE2.6x	S-76.7%	n/a
NWRN Newron Pharmaceuticals	CHF 6.03	-10.5%	-18.7%	CHF 120.4m	CHF 15.32	PE8.2x	E0.2%	n/a
MOLN Molecular Partners	CHF 3.24	7.8%	-9.5%	CHF 119.3m	CHF 10.50	PS24x	E-7.0%	n/a
XLS Xlife Sciences	CHF 19.40	3.2%	-50.9%	CHF 111.4m	n/a	PE5.2x	n/a	n/a
CURN Curatis Holding	CHF 9.80	-9.7%	n/a	CHF 48.9m	CHF 84.50	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 2.41	16.1%	92.8%	CHF 30.2m	n/a	PS3.6x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.05	-8.8%	-73.8%	CHF 4.9m	n/a	PS8.3x	E18.5%	n/a